glp-1 prescription requirements Updates for Employers: Demand, Shortages, and Cost How Employers Can Optimize Benefits

GLP-1 receptor agonists represent a breakthrough for managing type-2 diabetes and obesity, offering metabolic benefits across multiple organ systems

doi:10.1002/oby.24172

Learn what they contain, what the science actually says, and what truly supports people using GLP-1 medications.

Allergy medication and omeprazole are safe to take together for most people find out which antihistamines are compatible, what the BNF and NHS say, and when to seek advice.

Leading Players in the GLP-1 Market Novo Nordisk 38.72% Ozempic Wegovy Rybelsus Eli Lilly 28.41% Mounjaro Zepbound Sanofi 8.76% 4 AstraZeneca 6.62% 5 GSK 4.95% 6 Regeneron 3.27% 7 Pfizer 2.61% 8 Amgen 1.98% 9 Sun Pharma 1.52% Boehringer Ingelheim 1.24% Together, Novo Nordisk and Eli Lilly account for more than 67% of the market, highlighting the intense competition between the two companies that currently lead the obesity and diabetes treatment revolution